nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—Chloroprocaine—CHRNA10—nicotine dependence	0.0514	1	CrCbGaD
Lidocaine—Hoarseness—Varenicline—nicotine dependence	0.0372	0.0818	CcSEcCtD
Lidocaine—CYP2C18—Xenobiotics—CYP2A7—nicotine dependence	0.022	0.052	CbGpPWpGaD
Lidocaine—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0217	0.0511	CbGpPWpGaD
Lidocaine—Gingivitis—Varenicline—nicotine dependence	0.0209	0.0458	CcSEcCtD
Lidocaine—Dysphonia—Varenicline—nicotine dependence	0.0199	0.0437	CcSEcCtD
Lidocaine—Tenderness—Varenicline—nicotine dependence	0.0188	0.0412	CcSEcCtD
Lidocaine—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0175	0.0412	CbGpPWpGaD
Lidocaine—Dysarthria—Varenicline—nicotine dependence	0.0173	0.038	CcSEcCtD
Lidocaine—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0148	0.0349	CbGpPWpGaD
Lidocaine—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0147	0.0345	CbGpPWpGaD
Lidocaine—Euphoric mood—Varenicline—nicotine dependence	0.0141	0.0309	CcSEcCtD
Lidocaine—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0136	0.0322	CbGpPWpGaD
Lidocaine—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.0134	0.0317	CbGpPWpGaD
Lidocaine—Disorientation—Varenicline—nicotine dependence	0.0133	0.0292	CcSEcCtD
Lidocaine—Visual disturbance—Varenicline—nicotine dependence	0.0125	0.0275	CcSEcCtD
Lidocaine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0122	0.0286	CbGpPWpGaD
Lidocaine—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.012	0.0284	CbGpPWpGaD
Lidocaine—Osteoarthritis—Varenicline—nicotine dependence	0.0119	0.0261	CcSEcCtD
Lidocaine—Psychotic disorder—Varenicline—nicotine dependence	0.0116	0.0255	CcSEcCtD
Lidocaine—Urinary retention—Varenicline—nicotine dependence	0.0113	0.0248	CcSEcCtD
Lidocaine—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0108	0.0255	CbGpPWpGaD
Lidocaine—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0106	0.025	CbGpPWpGaD
Lidocaine—Asthma—Varenicline—nicotine dependence	0.0103	0.0226	CcSEcCtD
Lidocaine—Dysphagia—Varenicline—nicotine dependence	0.0103	0.0226	CcSEcCtD
Lidocaine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00948	0.0223	CbGpPWpGaD
Lidocaine—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00917	0.0216	CbGpPWpGaD
Lidocaine—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00915	0.0216	CbGpPWpGaD
Lidocaine—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00903	0.0213	CbGpPWpGaD
Lidocaine—Stomatitis—Varenicline—nicotine dependence	0.00892	0.0196	CcSEcCtD
Lidocaine—Bradycardia—Varenicline—nicotine dependence	0.00837	0.0184	CcSEcCtD
Lidocaine—Hypoaesthesia—Varenicline—nicotine dependence	0.00818	0.018	CcSEcCtD
Lidocaine—Visual impairment—Varenicline—nicotine dependence	0.00792	0.0174	CcSEcCtD
Lidocaine—Eye disorder—Varenicline—nicotine dependence	0.00768	0.0169	CcSEcCtD
Lidocaine—Tinnitus—Varenicline—nicotine dependence	0.00766	0.0168	CcSEcCtD
Lidocaine—Cardiac disorder—Varenicline—nicotine dependence	0.00763	0.0168	CcSEcCtD
Lidocaine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00753	0.0178	CbGpPWpGaD
Lidocaine—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00747	0.0176	CbGpPWpGaD
Lidocaine—Angiopathy—Varenicline—nicotine dependence	0.00746	0.0164	CcSEcCtD
Lidocaine—Immune system disorder—Varenicline—nicotine dependence	0.00742	0.0163	CcSEcCtD
Lidocaine—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00742	0.0175	CbGpPWpGaD
Lidocaine—Chills—Varenicline—nicotine dependence	0.00737	0.0162	CcSEcCtD
Lidocaine—Erythema—Varenicline—nicotine dependence	0.00715	0.0157	CcSEcCtD
Lidocaine—Dysgeusia—Varenicline—nicotine dependence	0.00701	0.0154	CcSEcCtD
Lidocaine—Back pain—Varenicline—nicotine dependence	0.00692	0.0152	CcSEcCtD
Lidocaine—Vision blurred—Varenicline—nicotine dependence	0.00674	0.0148	CcSEcCtD
Lidocaine—SCN9A—midbrain—nicotine dependence	0.00672	0.0969	CbGeAlD
Lidocaine—Tremor—Varenicline—nicotine dependence	0.0067	0.0147	CcSEcCtD
Lidocaine—Agitation—Varenicline—nicotine dependence	0.00657	0.0144	CcSEcCtD
Lidocaine—Angioedema—Varenicline—nicotine dependence	0.00654	0.0144	CcSEcCtD
Lidocaine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00638	0.015	CbGpPWpGaD
Lidocaine—Loss of consciousness—Varenicline—nicotine dependence	0.00629	0.0138	CcSEcCtD
Lidocaine—Convulsion—Varenicline—nicotine dependence	0.0062	0.0136	CcSEcCtD
Lidocaine—Hypertension—Varenicline—nicotine dependence	0.00618	0.0136	CcSEcCtD
Lidocaine—Chest pain—Varenicline—nicotine dependence	0.00609	0.0134	CcSEcCtD
Lidocaine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00608	0.0143	CbGpPWpGaD
Lidocaine—Anxiety—Varenicline—nicotine dependence	0.00607	0.0133	CcSEcCtD
Lidocaine—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.006	0.0142	CbGpPWpGaD
Lidocaine—SCN5A—cardiovascular system—nicotine dependence	0.00595	0.0859	CbGeAlD
Lidocaine—Oedema—Varenicline—nicotine dependence	0.00584	0.0128	CcSEcCtD
Lidocaine—Shock—Varenicline—nicotine dependence	0.00574	0.0126	CcSEcCtD
Lidocaine—Nervous system disorder—Varenicline—nicotine dependence	0.00573	0.0126	CcSEcCtD
Lidocaine—Hyperhidrosis—Varenicline—nicotine dependence	0.00564	0.0124	CcSEcCtD
Lidocaine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00558	0.0131	CbGpPWpGaD
Lidocaine—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0055	0.013	CbGpPWpGaD
Lidocaine—Hypotension—Varenicline—nicotine dependence	0.00546	0.012	CcSEcCtD
Lidocaine—SCN2A—midbrain—nicotine dependence	0.0053	0.0765	CbGeAlD
Lidocaine—Dyspnoea—Varenicline—nicotine dependence	0.00521	0.0114	CcSEcCtD
Lidocaine—Somnolence—Varenicline—nicotine dependence	0.00519	0.0114	CcSEcCtD
Lidocaine—EGFR—brain—nicotine dependence	0.00513	0.074	CbGeAlD
Lidocaine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00504	0.0111	CcSEcCtD
Lidocaine—Pain—Varenicline—nicotine dependence	0.00499	0.011	CcSEcCtD
Lidocaine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00493	0.0116	CbGpPWpGaD
Lidocaine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00492	0.0116	CbGpPWpGaD
Lidocaine—Feeling abnormal—Varenicline—nicotine dependence	0.00481	0.0106	CcSEcCtD
Lidocaine—SCN3A—midbrain—nicotine dependence	0.00466	0.0673	CbGeAlD
Lidocaine—Urticaria—Varenicline—nicotine dependence	0.00464	0.0102	CcSEcCtD
Lidocaine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00452	0.0107	CbGpPWpGaD
Lidocaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0045	0.0106	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00448	0.0106	CbGpPWpGaD
Lidocaine—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00444	0.0105	CbGpPWpGaD
Lidocaine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0044	0.0104	CbGpPWpGaD
Lidocaine—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00434	0.0102	CbGpPWpGaD
Lidocaine—Hypersensitivity—Varenicline—nicotine dependence	0.0043	0.00945	CcSEcCtD
Lidocaine—SCN9A—brain—nicotine dependence	0.00422	0.0609	CbGeAlD
Lidocaine—Asthenia—Varenicline—nicotine dependence	0.00419	0.00921	CcSEcCtD
Lidocaine—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00418	0.00985	CbGpPWpGaD
Lidocaine—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00394	0.00929	CbGpPWpGaD
Lidocaine—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00389	0.00916	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00387	0.00912	CbGpPWpGaD
Lidocaine—Dizziness—Varenicline—nicotine dependence	0.00386	0.00848	CcSEcCtD
Lidocaine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00381	0.00898	CbGpPWpGaD
Lidocaine—SCN4A—brain—nicotine dependence	0.00377	0.0543	CbGeAlD
Lidocaine—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00376	0.00886	CbGpPWpGaD
Lidocaine—Vomiting—Varenicline—nicotine dependence	0.00371	0.00816	CcSEcCtD
Lidocaine—Rash—Varenicline—nicotine dependence	0.00368	0.00809	CcSEcCtD
Lidocaine—Dermatitis—Varenicline—nicotine dependence	0.00368	0.00808	CcSEcCtD
Lidocaine—Headache—Varenicline—nicotine dependence	0.00366	0.00804	CcSEcCtD
Lidocaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00365	0.0086	CbGpPWpGaD
Lidocaine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00357	0.0084	CbGpPWpGaD
Lidocaine—Nausea—Varenicline—nicotine dependence	0.00347	0.00762	CcSEcCtD
Lidocaine—SCN2A—brain—nicotine dependence	0.00333	0.0481	CbGeAlD
Lidocaine—SCN10A—brain—nicotine dependence	0.00321	0.0464	CbGeAlD
Lidocaine—EGFR—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00318	0.00751	CbGpPWpGaD
Lidocaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00313	0.00737	CbGpPWpGaD
Lidocaine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0031	0.00731	CbGpPWpGaD
Lidocaine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00309	0.00728	CbGpPWpGaD
Lidocaine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00309	0.00727	CbGpPWpGaD
Lidocaine—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00306	0.00721	CbGpPWpGaD
Lidocaine—CYP2B6—cardiovascular system—nicotine dependence	0.003	0.0433	CbGeAlD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00299	0.00705	CbGpPWpGaD
Lidocaine—CYP2C9—cardiovascular system—nicotine dependence	0.00297	0.0429	CbGeAlD
Lidocaine—SCN3A—brain—nicotine dependence	0.00293	0.0423	CbGeAlD
Lidocaine—CYP2A6—brain—nicotine dependence	0.00293	0.0422	CbGeAlD
Lidocaine—SCN5A—brain—nicotine dependence	0.00292	0.0421	CbGeAlD
Lidocaine—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00278	0.00655	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00272	0.0064	CbGpPWpGaD
Lidocaine—SLC22A5—midbrain—nicotine dependence	0.0027	0.039	CbGeAlD
Lidocaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00265	0.00624	CbGpPWpGaD
Lidocaine—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00262	0.00618	CbGpPWpGaD
Lidocaine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00261	0.00616	CbGpPWpGaD
Lidocaine—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00258	0.00609	CbGpPWpGaD
Lidocaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00254	0.00598	CbGpPWpGaD
Lidocaine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00251	0.00592	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00241	0.00567	CbGpPWpGaD
Lidocaine—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.0024	0.00566	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00231	0.00544	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—FGD1—nicotine dependence	0.0023	0.00541	CbGpPWpGaD
Lidocaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00215	0.00506	CbGpPWpGaD
Lidocaine—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00206	0.00485	CbGpPWpGaD
Lidocaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00204	0.00482	CbGpPWpGaD
Lidocaine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00202	0.00476	CbGpPWpGaD
Lidocaine—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00201	0.00474	CbGpPWpGaD
Lidocaine—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00194	0.00457	CbGpPWpGaD
Lidocaine—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00191	0.0045	CbGpPWpGaD
Lidocaine—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00189	0.00446	CbGpPWpGaD
Lidocaine—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00187	0.0044	CbGpPWpGaD
Lidocaine—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00174	0.0041	CbGpPWpGaD
Lidocaine—SLC22A5—brain—nicotine dependence	0.0017	0.0245	CbGeAlD
Lidocaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00166	0.00391	CbGpPWpGaD
Lidocaine—CYP2C8—brain—nicotine dependence	0.00164	0.0237	CbGeAlD
Lidocaine—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00164	0.00387	CbGpPWpGaD
Lidocaine—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00162	0.00381	CbGpPWpGaD
Lidocaine—ABCB1—cardiovascular system—nicotine dependence	0.00161	0.0232	CbGeAlD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00152	0.00358	CbGpPWpGaD
Lidocaine—CYP2B6—brain—nicotine dependence	0.00147	0.0213	CbGeAlD
Lidocaine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00143	0.00337	CbGpPWpGaD
Lidocaine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00142	0.00334	CbGpPWpGaD
Lidocaine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00135	0.00317	CbGpPWpGaD
Lidocaine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00134	0.00315	CbGpPWpGaD
Lidocaine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00133	0.00313	CbGpPWpGaD
Lidocaine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00132	0.0031	CbGpPWpGaD
Lidocaine—ABCB1—midbrain—nicotine dependence	0.00125	0.0181	CbGeAlD
Lidocaine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00121	0.00285	CbGpPWpGaD
Lidocaine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00114	0.00269	CbGpPWpGaD
Lidocaine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00113	0.00265	CbGpPWpGaD
Lidocaine—CYP2D6—brain—nicotine dependence	0.0011	0.0158	CbGeAlD
Lidocaine—EGFR—Signaling by GPCR—TAS2R16—nicotine dependence	0.00106	0.00251	CbGpPWpGaD
Lidocaine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000934	0.0022	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000881	0.00208	CbGpPWpGaD
Lidocaine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000868	0.00205	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—FGD1—nicotine dependence	0.000835	0.00197	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—WASF2—nicotine dependence	0.000815	0.00192	CbGpPWpGaD
Lidocaine—ABCB1—brain—nicotine dependence	0.000788	0.0114	CbGeAlD
Lidocaine—EGFR—Innate Immune System—WASF1—nicotine dependence	0.000781	0.00184	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000674	0.00159	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TAS2R16—nicotine dependence	0.000628	0.00148	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKR1B10—nicotine dependence	0.000622	0.00147	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000522	0.00123	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGD1—nicotine dependence	0.000493	0.00116	CbGpPWpGaD
Lidocaine—EGFR—Immune System—WASF2—nicotine dependence	0.000475	0.00112	CbGpPWpGaD
Lidocaine—EGFR—Immune System—WASF1—nicotine dependence	0.000455	0.00107	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—OPRM1—nicotine dependence	0.000448	0.00106	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000448	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKR1B10—nicotine dependence	0.000436	0.00103	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000411	0.000968	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000331	0.000781	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—DRD2—nicotine dependence	0.000324	0.000764	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000324	0.000763	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—WASF2—nicotine dependence	0.000307	0.000723	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—WASF1—nicotine dependence	0.000294	0.000693	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000281	0.000661	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—OPRM1—nicotine dependence	0.000265	0.000624	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000244	0.000576	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.00023	0.000543	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000228	0.000538	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000195	0.00046	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—DRD2—nicotine dependence	0.000192	0.000451	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000151	0.000355	CbGpPWpGaD
